Blog / Archives
Biotechs Stalled and Get No Help From Monday’s Market Moves…Updates
Updates: 4/19/18 GWPH hits $143 new high, then sold off holding $134 level, after big move from $105 on cannabis drug for severe epilepsy FDA Advisory go ahead. Biotechs broadly in the red except...
Biotechs Bounce off Bottom on Novartis Deal but Fades Later in the Day…Updates
Updates 4/11/18 Biotechs Holding Above Recent Bottom 4/6/18 FBT up 2.8% over 5 days, up 6% YTD XBI up 1.77% over 5 days, up 2.19% YTD IBB down 0.72% over 5 days, down 3.67% YTD Busted Biotechs...
Busted Biotech Stocks: Where Do We Go From Here?…Updates
4/17/18 Latest portfolio changes are working: CELG at $88, XBI at $84. all based on technicals. ========== Busted Biotech Stocks Get No Help From the Overall Market 4/8 Update XBI down 3% on 4/6 and...
2018 Large Cap Biopharmaceutical Stocks : First Quarter Performance Update
2018 Large Cap Biopharmaceuticals - Performance Compared to ETFs It has been a rough start for large cap biopharmaceutical stocks but the ETFs (FBT) and (XBI) still outperformed the SPY YTD and over...
Rayno BioBeat #3…Biotech Bull Market Intact Despite Shaky Start… Update-1
4/2/18 12:30P Update Biotechs break through 2018 support levels with XBI now needs to hold December lows at $80. IBB at double bottom hit in November/December at $102 level. Watch Mid-Cap list below...
Market Rout: Biotechs Busted In Turmoil From Tariffs…Updates
Sell-Off Gets Scary--NASDAQ Futures Still Down at 1:30A EDT 3/28 Double Bottom -Double Top on XBI and Testing February Lows at $87 Another Sell-Off=Tuesday Movers 3/27/18 Large Caps % Up-NONE FBT...
Biotech Green Day Despite Tech Turmoil: Good Tape Action…Update-2 ABBV
Update-2...3/22 ABBV News Kills Momentum of Biotech Stocks 12:30P EDT Abbvie (ABBV) down 13.5 % on disappointing results on blood cancer drug. The big issue is that the drug was recently acquired...
Broad Sell-Off Nails Biotech Stocks As Well…Update-1
Update-1... 3/19. Close is off the lows for Biotech Indices QQQ gap down to $167.10 also at SMA 50 XBI at SMA 50 bottom of channel at $91.89 XLV at $84 approaching February lows of $81 It is very...
Weak NASDAQ Leaves Biotech Stocks Stalled…Update-1
Update-1 ...March 18- Market jittery on potential global trade war, rising interest rate concerns and political risk. Also Sales to U.S. retailers fell 0.1% in February a 3 month slide....
Biotechs Buffeted by Macro News But Should Continue to Outperform…Update-1
Update-1 March 10... Broad Rally Continues Through The Week QQQ Up 4.3% IBB up 4.3% XBI up 4.8% Gene Editing Stocks Surge Biotech stocks soared along with the market as fear about interest rates,...